Skip to main content
. 2017 Jan 30;72(5):1469–1477. doi: 10.1093/jac/dkw578

Figure 2.

Figure 2

Percentage of E. coli and K. pneumoniae isolates resistant by antimicrobial drug and patient characteristics. 1, community based; 2, hospital associated; AMP, ampicillin; AMC, amoxicillin/clavulanic acid; SAM, ampicillin/sulbactam; TZP, piperacillin/tazobactam; FEP, cefepime; CTX, ceftriaxone; CXM, cefuroxime; CAZ, ceftazidime; ETP, ertapenem; MEM, meropenem; GEN, gentamicin; AMK, amikacin; CIP, ciprofloxacin; LVX, levofloxacin; SXT, trimethoprim/sulfamethoxazole; NIT, nitrofurantoin; TGC, tigecycline; FOS, fosfomycin.